DiscGenics
DiscGenics develops tissue engineering and progenitor cell science for the treatment of degenerative disc disease. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
€182—273m (Dealroom.co estimates Aug 2020.)
Salt Lake City Utah (HQ)
Authorizing premium user...